Duncker Streett & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,465
| Closed | -$642K | – | 563 |
|
|
2019
Q3 | $642K | Sell |
6,465
-1,900
| -23% | -$181K | 0.15% | 151 |
|
|
2019
Q2 | $773K | Sell |
8,365
-400
| -5% | -$38K | 0.17% | 137 |
|
|
2019
Q1 | $827K | Buy |
8,765
+1,070
| +14% | +$93.6K | 0.19% | 128 |
|
|
2018
Q4 | $493K | Sell |
7,695
-1,040
| -12% | -$76.8K | 0.13% | 164 |
|
|
2018
Q3 | $782K | Buy |
8,735
+230
| +3% | +$20.3K | 0.18% | 141 |
|
|
2018
Q2 | $675K | Sell |
8,505
-4,200
| -33% | -$349K | 0.17% | 148 |
|
|
2018
Q1 | $1.13M | Buy |
12,705
+520
| +4% | +$49.9K | 0.29% | 110 |
|
|
2017
Q4 | $1.27M | Buy |
12,185
+1,640
| +16% | +$185K | 0.33% | 97 |
|
|
2017
Q3 | $1.54M | Buy |
10,545
+2,990
| +40% | +$407K | 0.47% | 68 |
|
|
2017
Q2 | $981K | Buy |
7,555
+640
| +9% | +$78.4K | 0.31% | 98 |
|
|
2017
Q1 | $860K | Buy |
6,915
+420
| +6% | +$50.3K | 0.27% | 107 |
|
|
2016
Q4 | $752K | Buy |
6,495
+340
| +6% | +$37.9K | 0.25% | 113 |
|
|
2016
Q3 | $643K | Sell |
6,155
-100
| -2% | -$10.8K | 0.22% | 125 |
|
|
2016
Q2 | $617K | Hold |
6,255
| – | – | 0.22% | 117 |
|
|
2016
Q1 | $626K | Sell |
6,255
-400
| -6% | -$41.2K | 0.23% | 117 |
|
|
2015
Q4 | $797K | Sell |
6,655
-400
| -6% | -$46.3K | 0.3% | 96 |
|
|
2015
Q3 | $763K | Sell |
7,055
-520
| -7% | -$64.5K | 0.3% | 95 |
|
|
2015
Q2 | $877K | Sell |
7,575
-2,000
| -21% | -$229K | 0.31% | 96 |
|
|
2015
Q1 | $1.1M | Buy |
9,575
+200
| +2% | +$23.9K | 0.36% | 82 |
|
|
2014
Q4 | $1.05M | Buy |
9,375
+300
| +3% | +$31.6K | 0.34% | 87 |
|
|
2014
Q3 | $860K | Buy |
9,075
+850
| +10% | +$76.7K | 0.29% | 108 |
|
|
2014
Q2 | $706K | Buy |
8,225
+4,175
| +103% | +$317K | 0.23% | 128 |
|
|
2014
Q1 | $283K | Buy |
4,050
+250
| +7% | +$19.8K | 0.1% | 211 |
|
|
2013
Q4 | $321K | Hold |
3,800
| – | – | 0.12% | 192 |
|
|
2013
Q3 | $293K | Sell |
3,800
-4,000
| -51% | -$280K | 0.12% | 189 |
|
|
2013
Q2 | $456K | Buy |
+7,800
| New | +$469K | 0.17% | 150 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Duncker Streett & Co's CELG Position: Q4 2019 in Review
Duncker Streett & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,465 shares — an estimated $642K sold.
Duncker Streett & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.54M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Duncker Streett & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Duncker Streett & Co sold 6,465 Celgene Corp shares in Q4 2019, an estimated $642K.
- Duncker Streett & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Duncker Streett & Co's Celgene Corp position peaked at $1.54M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Duncker Streett & Co's 13F filing for Q4 2019, filed 27 Jan 2020.